Cancer vaccine NY-ESO-1 (Therion Biologics)
N/A
Report date: 2022/02/28 17:59:09
Base Information
Drug NameCancer vaccine NY-ESO-1 (Therion Biologics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTherion BiologicsLudwig Institute For Cancer Research
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesTherion BiologicsLudwig Institute For Cancer Research
Active IndicationsN/A
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A